Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
841.40
Change Change %
-18.55 -2.16%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
838.00
Change Change %
-23.85 -2.77%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
11-04-2016 Buy 1023.00 1140.00
N/A
Target Hit Long (1Y)
11-04-2017

Citi initiates Dr. Lal Pathlabs with buy

Company is a multi-year growth play. High return ratio will drive higher earnings multiples. See potentially higher dividends in the company. See a 50 per cent premium to average Asian hospitals.

Top